Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
NanoViricides, Inc. (NNVC) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.22M |
|
-- |
|
-- |
|
$2.25M |
|
$-2.25M |
|
$0.02M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.25M |
|
$-2.12M |
|
20.19M |
|
20.19M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$3.16M |
|
$6.40M |
|
$6.71M |
|
$9.87M |
|
$1.19M |
|
-- |
|
-- |
|
$1.19M |
|
$8.68M |
|
$8.37M |
|
$8.68M |
|
23.01M |
|
| Cash Flow Statement Financials | |
$-7.70M |
|
$-0.08M |
|
$9.02M |
|
$1.56M |
|
$2.79M |
|
$1.24M |
|
$0.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.66 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.78M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.61% |
|
-26.55% |
|
-22.52% |
|
-25.61% |
|
$0.38 |
|
$-0.39 |
|
$-0.38 |
|